Trust Point Inc. Takes $239,000 Position in Phreesia, Inc. (NYSE:PHR)

Trust Point Inc. acquired a new position in Phreesia, Inc. (NYSE:PHR) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 10,311 shares of the company’s stock, valued at approximately $239,000.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Acadian Asset Management LLC bought a new stake in shares of Phreesia in the 1st quarter valued at about $43,000. Captrust Financial Advisors lifted its stake in shares of Phreesia by 154.6% in the second quarter. Captrust Financial Advisors now owns 1,426 shares of the company’s stock worth $36,000 after acquiring an additional 866 shares during the period. State of Wyoming boosted its holdings in Phreesia by 34.6% in the second quarter. State of Wyoming now owns 1,918 shares of the company’s stock valued at $59,000 after acquiring an additional 493 shares during the last quarter. Tower Research Capital LLC TRC increased its position in Phreesia by 85.4% during the 3rd quarter. Tower Research Capital LLC TRC now owns 3,137 shares of the company’s stock valued at $80,000 after purchasing an additional 1,445 shares during the period. Finally, Point72 Hong Kong Ltd raised its holdings in Phreesia by 266.6% during the 1st quarter. Point72 Hong Kong Ltd now owns 5,381 shares of the company’s stock worth $142,000 after purchasing an additional 3,913 shares during the last quarter. 92.10% of the stock is currently owned by institutional investors and hedge funds.

Phreesia Stock Performance

Shares of PHR stock opened at $21.79 on Monday. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.02. The firm has a fifty day simple moving average of $24.96 and a two-hundred day simple moving average of $20.98. Phreesia, Inc. has a 12 month low of $12.05 and a 12 month high of $34.98. The firm has a market capitalization of $1.23 billion, a PE ratio of -8.65 and a beta of 0.92.

Phreesia (NYSE:PHR) last posted its earnings results on Thursday, March 14th. The company reported ($0.56) EPS for the quarter, topping the consensus estimate of ($0.58) by $0.02. Phreesia had a negative net margin of 38.42% and a negative return on equity of 53.33%. The company had revenue of $95.00 million during the quarter, compared to the consensus estimate of $93.52 million. During the same period in the previous year, the firm posted ($0.72) earnings per share. The firm’s revenue for the quarter was up 24.0% on a year-over-year basis. Analysts forecast that Phreesia, Inc. will post -1.46 EPS for the current fiscal year.

Insider Transactions at Phreesia

In related news, General Counsel Allison C. Hoffman sold 1,316 shares of the company’s stock in a transaction on Tuesday, January 16th. The stock was sold at an average price of $24.55, for a total transaction of $32,307.80. Following the completion of the sale, the general counsel now owns 144,464 shares in the company, valued at $3,546,591.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other Phreesia news, COO Evan Roberts sold 2,247 shares of Phreesia stock in a transaction that occurred on Tuesday, January 16th. The shares were sold at an average price of $24.55, for a total transaction of $55,163.85. Following the transaction, the chief operating officer now owns 795,613 shares of the company’s stock, valued at approximately $19,532,299.15. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, General Counsel Allison C. Hoffman sold 1,316 shares of the business’s stock in a transaction that occurred on Tuesday, January 16th. The stock was sold at an average price of $24.55, for a total value of $32,307.80. Following the completion of the transaction, the general counsel now owns 144,464 shares in the company, valued at approximately $3,546,591.20. The disclosure for this sale can be found here. Insiders sold a total of 39,344 shares of company stock valued at $936,390 over the last ninety days. 5.80% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the stock. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $23.00 price objective on shares of Phreesia in a research note on Thursday, March 21st. Truist Financial started coverage on Phreesia in a research report on Monday, February 26th. They issued a “buy” rating and a $35.00 price objective for the company. Barclays assumed coverage on Phreesia in a research report on Wednesday, January 3rd. They set an “overweight” rating and a $29.00 target price on the stock. Raymond James reiterated an “outperform” rating and issued a $30.00 target price (up from $25.00) on shares of Phreesia in a report on Friday, March 15th. Finally, DA Davidson restated a “neutral” rating and set a $32.00 price target on shares of Phreesia in a report on Friday, March 15th. Two research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $31.62.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.